换一批
换一批摘要由于诊疗手段的不断改进,霍奇金淋巴瘤已成为治愈率较高的恶性肿瘤.但随着患者生存期的延长,治疗的远期不良反应越来越受到临床医生的关注.因此,根据疾病分期和危险因素对患者实施个体化治疗是目前霍奇金淋巴瘤的研究热点.本文综述了近年来早期经典型霍奇金淋巴瘤在个体化治疗方面的研究进展.
更多相关知识
abstractsMuch progress has been made in the diagnosis and treatment of Hodgkin's lymphoma, which has become a highly curable malignancy.However, prolonged survival makes clinicians pay more attention to long-term toxicities of treatment.Consequently, individualized treatment based on disease stage and risk factors is a research hotspot at present.This article reviews recent advances in the individualized treatment of early-stage classical Hodgkin's lymphoma.
More相关知识
关键词
霍奇金病/放射疗法霍奇金病/化学疗法风险评估体层摄影术,正电子发射型Hodgkin disease/radiotherapyHodgkin disease/chemotherapyRisk assessmentTomographypositron-emission
栏目名称
综述
DOI
10.3760/cma.j.issn.1004-4221.2017.05.022
发布时间
2017-05-31
- 浏览100
- 被引0
- 下载282
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
